[1]
Mishra, A., Shrestha, S., K.C., S. and Karn, D. 2022. A Prospective Clinical Study for Safety and Efficacy of Intralesional Tuberculin Purified Protein Derivative in Treatment of Palmoplantar Verruca. Journal of Nobel Medical College. 11, 1 (Jun. 2022), 12–16. DOI:https://doi.org/10.3126/jonmc.v11i1.45720.